Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.28% rallied 1.06% to $171.79 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.91% rising 1.01% to 4,411.79 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.48% rising 0.68% to 35,061.55. This was the stock's fourth consecutive day of gains. Johnson & Johnson closed $1.86 below its 52-week high ($173.65), which the company achieved on January 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -2.06% fell 1.14% to $370.25, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.40% rose 1.32% to $77.54, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -1.30% rose 0.51% to $41.68. Trading volume (5.0 M) remained 1.6 million below its 50-day average volume of 6.6 M.